Stay updated on GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    - The page footer now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1 as a minor update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T13:33:23.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, with no changes to study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T23:32:26.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The Study Record Dates section now displays Last Update Posted as the actual posting date and removes the Last Update Posted (Estimated) label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-22T09:27:48.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision update from v3.3.3 to v3.3.4 with no visible changes to the study content.
    Difference
    0.0%
    Check dated 2026-01-15T04:48:30.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added Sarah Cannon Research Institute at Mary Crowley as a recruitment site and removed Mary Crowley Cancer Research as a recruitment site. The update also includes a December 2025 Last Update Posted (Estimated) timestamp.
    Difference
    0.3%
    Check dated 2026-01-01T00:19:31.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Location sections were added for California, Connecticut, Massachusetts, Tennessee, Texas, Wisconsin, New South Wales, and Victoria. The corresponding location sections for those areas were removed in the prior revision.
    Difference
    0.8%
    Check dated 2025-12-17T18:36:32.000Z thumbnail image

Stay in the know with updates to GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.